_edited.jpg)
Join us for Facing Heterotaxy Together, the premier conference bringing together families, clinicians, and researchers to advance understanding, support, and treatment of Heterotaxy. In partnership with Heterotaxy Connection and the Benderson Family Heart Center at Boston Children's Hospital, for the first time ever we are combining our scientific and family conferences in one event, offering dedicated programming in two tracks.
Clinician Track: Cutting-edge research, clinical advancements, networking opportunities, and collaborative discussions among medical professionals.
Family Track: Support, education, and community-building sessions for individuals and families affected by Heterotaxy. Families interested in clinical programming will be welcome to attend general sessions.
October 9-12, 2025
Early bird pricing is available.
This conference will foster meaningful connections between those living with Heterotaxy and the experts working to improve care and outcomes.
​
Clinicians in training can register for free. CME's will be available through Boston Children's Hospital.
​
Agenda is now available!
Agenda: Clinician Track
.png)
Call For Abstracts
HRC3, in partnership with Heterotaxy Connection and Benderson Family Heart Center, invites the submission of abstracts and case reports for presentation at the 2025 Facing Heterotaxy Together Conference.
CONTENT OF ABSTRACTS OR CASE REPORTS
SCIENTIFIC ABSTRACTS
Accepted scientific abstracts (basic science or clinical research) will be presented as a poster or oral presentation.
Scientific abstracts must contain:
​
-
A descriptive title, list of authors and institutions;
-
An introduction / rationale to the study;
-
The methods used;
-
The results of the study;
-
Conclusions of the study.
CASE REPORTS
Accepted case reports will be presented in the form of a poster or oral presentation.
Case reports must contain:​
​
-
A descriptive title, list of authors and institutions;
-
An introduction;
-
A detailed description of the case;
-
A discussion of the novelty and importance of the scientific case
Language: All abstracts and case reports must be submitted and presented in English.
Funding source: All abstracts must specify the funding source(s).
Co-authors: All authors listed on the abstract must have knowledge of the abstract submission.
Disclosure: It is required that the primary author disclose any potential conflicts of interest.
Abstract length: The total word count may not exceed 500 words. Title, authors' information, institutions, tables, images, and spaces between words do not count towards the 500-word count.
Abbreviations: Abbreviations should be spelled out on the first occurrence in the text.
Tables/Images: You may include 1 table or figure.
SCHOLARSHIPS / AWARDS
Presenters of abstracts selected for an oral presentation will be offered free registration and lodging at the conference hotel.
​
Additional financial gifts will be awarded to the top abstracts.
ABSTRACT PRESENTATION
-
The person assigned as the presenting author will be expected to present at the conference.
-
Authors assigned to a poster presentation will be expected to display illustrative material in the form of a poster.
-
Authors assigned to an oral presentation will be expected to prepare a 10 minute presentation with Power Point visual aids. This will be followed by a 5 minute question and answer period.
-
Posters will be presented during the poster session on Friday, October 10th from 5-6:30PM.
-
Oral presentations will be delivered on Saturday, October 11th in the morning.
POSTER GUIDELINES
Poster set-up and take-down instructions will be provided on site. Posters must be formatted to one of the following two dimensions:
​
-
48"w x 36"h (122cm w x 91cm h)
-
60"w x 36"h (152cm w x 91cm h)
SUBMISSION
Abstracts are to be submitted in Microsoft Word format to hrc3@heterotaxy.org
​
Abstracts which have already been presented at previous meetings can be submitted provided they offer information pertinent to the study of Heterotaxy.
NOTIFICATIONS AND DEADLINES
Notification of abstract / case report acceptance or rejection will be sent electronically to the presenting author within 2-3 weeks of the deadline.​
​
The body of the submission email must contain the following:
-
Name of presenting author
-
Address, email address, and phone number of presenting author
-
Title of abstract / case report
DEADLINE
September 1, 2025 by 5:00PM Eastern
At the Facing Heterotaxy Together Scientific Conference, in September 2024, clinical and research experts in various subspecialty fields from across the country presented detailed reviews of clinical manifestations, management recommendations, and research in the field of heterotaxy.
​
Full recordings are available to view and share.
Conference Chairs
-
Thomas G. Saba, MD, Pediatric Pulmonology, C.S. Mott Children’s Hospital, University of Michigan Medical School
-
David N. Schidlow, MD, MMus, Pediatric Cardiology, Director – Heterotaxy Program, Boston Children’s Hospital, Harvard Medical School
-
Stephanie M. Ware, MD PhD, Department of Medical and Molecular Genetics, Director of Cardiovascular Genetics, Indiana University School of Medicine, and Riley Children’s Hospital at Indiana University Health
Objectives
-
Establish a united approach to heterotaxy care and research
-
Gain a better understanding of the diverse clinical features of heterotaxy
-
Facilitate national networks for clinical, basic science, translational and health services research
-
Build tools and expertise for local heterotaxy program development
-
Create a foundation for a future national registry
Speakers (listed alphabetically)
-
Christopher R. Broda, MD, Adult Congenital Heart Disease Program, Baylor College of Medicine
-
Emily Bucholz, MD MPH PhD, Pediatric Cardiology, University of Colorado Anschutz Medical Campus
-
Kathryn Chatfield, MD PhD, Cardiac Genetics, University of Colorado Anschutz Medical Campus
-
Andrea S. Garrod, MD, Pediatric Pulmonology, University of Virginia School of Medicine
-
Elle Geddes, MD, Medical and Molecular Genetics, Indiana University School of Medicine
-
Kenan Haver, MD, Pediatric Pulmonology, Boston Children’s Hospital
-
David Hoganson, MD, Cardiac Surgery, Boston Children's Hospital
-
Gerald Marx, MD, Pediatric Cardiology, Boston Children’s Hospital
-
Cecilia W. Lo, PhD, Developmental Biology, University of Pittsburgh
-
Douglas R. McDonald, MD PhD, Pediatric Immunology, Boston Children’s Hospital
-
Caitlin O’Connell, DNP, Boston Children’s Hospital
-
David Schidlow, MD MMUs, Pediatric Cardiology, Boston Children’s Hospital
-
Adam Shapiro, MD, Pediatric Respirology, McGill University School of Medicine
-
Steven Spurgin, MD, Pediatric Cardiology, Children's Health - Dallas, UT Southwestern Medical Center
-
Michaela S. Tracy, MD, Pediatric Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital
-
Stephanie Ware, MD PhD, Medical and Molecular Genetics, Indiana University School of Medicine